首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1560822

全球診斷影像設備市場 - 2024 - 2031

Global Diagnostic Imaging Equipment Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球診斷影像設備市場2023年達到445億美元，預計到2031年將達到660.6億美元，2024-2031年預測期間複合年成長率為5.2%。

診斷影像描述了觀察身體內部的各種技術，以幫助找出疾病或受傷的原因並確認診斷。診斷健康影像技術已經改變了醫療保健，現在可以更早診斷醫療狀況，減少不必要的侵入性探索過程的需要，並創造更好的患者治療結果。診斷影像技術應用於骨科、神經科、婦產科、腫瘤學、心臟科、牙科等各個醫學領域。

診斷影像是一種非侵入性影像測試的醫療技術，透過獲取患者身體內部結構和器官的視覺影像來診斷和監測疾病或損傷。醫生廣泛使用診斷影像技術來檢查和診斷患者的確切醫療狀況。它有助於識別心臟異常、骨折、動脈瘤、胃腸道問題和各種類型的癌症。診斷影像也用於監測患者的身體對治療的反應。診斷影像可以及早診斷疾病並顯著改善患者的生存結果。這是一種無痛技術，可提供快速診斷。診斷影像產業已經發生了從床邊監測到高階數位掃描的徹底變革。

市場動態：

司機

慢性病盛行率增加

各種慢性病盛行率的上升推動了市場的成長。例如，根據 nih.gov 2023 年 1 月發表的一篇文章，預計 2023 年美國將出現 1,958,310 例新癌症病例和 609,820 例癌症死亡。在經歷了二十年的下降之後，從 2014 年到 2019 年，前列腺癌的發生率每年增加 3%，意味著新增病例增加了 99,000 例。

此外，根據wcrf.org 的數據，包括非黑色素瘤皮膚癌(NMSC) 在內，2022 年全球癌症病例數為19,976,499 例。男性女性 9,175,141 人。此外，根據 IARC 的數據，2022 年將有近 2,000 萬新發癌症病例（包括非黑色素瘤皮膚癌 [NMSC]），同時有 970 萬人死於癌症（包括 NMSC）。據估計，大約五分之一的男性或女性一生中會罹患癌症，而大約九分之一的男性和十二分之一的女性會死於癌症。肺癌是 2022 年最常被診斷出的癌症，導致近 250 萬新病例，即全球八分之一的癌症之一（佔全球所有癌症的 12.4%）。

限制

治療相關的高成本、缺乏醫療基礎設施以及缺乏熟練專業人員等因素預計將阻礙市場。

細分市場分析

全球診斷成像設備市場根據產品類型、應用、最終用戶和地區進行細分。

X光約佔全球診斷影像設備市場佔有率的48.6%

X光領域預計將在預測期內佔據最大的市場佔有率。在這一領域，技術進步推動了這個市場。

X光是電磁輻射的一種形式，類似於可見光。然而，與光不同的是，X光具有更高的能量，可以穿過大多數物體，包括身體。醫用 X 光用於產生體內組織和結構的圖像。如果穿過身體的 X 光也穿過病人另一側的 X 光偵測器，就會形成代表體內物體形成的「陰影」的影像。

例如，2024 年 1 月，Carestream Health 推出了一款名為 DXR-Excel Plus 的新型 X 光系統，其功能旨在幫助簡化工作流程並提高生產力。 DXR-Excel Plus 是一款適用於螢光透視和普通放射學的二合一系統，可為各種檢查提供即時影像，同時提供有助於為使用者、患者和管理員創造增強體驗的功能。

市場地域佔有率

北美約佔全球診斷影像設備市場佔有率的42.8%

預計北美地區將在預測期內佔據最大的市場佔有率。該地區慢性病發病率的上升和技術進步有助於推動市場發展。

例如，根據 nih.gov 2024 年 1 月發表的一篇文章，預計 2024 年美國將出現 2,001,140 例新癌症病例和 611,720 例癌症死亡。到 2021 年，癌症死亡率持續下降，由於吸菸的減少、某些癌症的早期發現以及輔助和轉移治療方案的改進，自 1991 年以來避免了超過 400 萬人死亡。然而，這些成果受到十大癌症中六種發病率上升的威脅。

此外，2024 年 6 月，史密斯探測推出了採用衍射技術 SDX 10060 XDi 的最新 X 光掃描儀。 X光衍射 (XRD) 是一種強大的檢測技術，可根據物體的分子結構提供高精度的材料辨別和物質識別。 XRD 特別適合檢測不斷變化的粉末、液體或固體形式的化合物，例如「自製」爆炸物或麻醉劑，甚至對於密度相似的材料也是如此。

Diagnostic imaging describes various techniques of viewing the inside of the body to help figure out the causes of an illness or injury and confirm a diagnosis. Diagnostic health imaging technology has transformed healthcare and now allows for earlier diagnosis of medical conditions, reduces the need for needless invasive exploratory processes, and creates better patient outcomes. Diagnostic imaging technology is applied in various fields of medicine like orthopedics, neurology, obstetrics/gynecology, oncology, cardiology, dental, and others.

Diagnostic imaging is a medical technique of non-invasive imaging tests for diagnosing and monitoring diseases or injuries by getting visual images of internal structures and organs of the patient's body. Diagnostic imaging technologies are used extensively by doctors to examine and diagnose the exact medical conditions of patients. It helps identify cardiac abnormalities, broken bones, aneurysms, gastrointestinal issues, and various types of cancer. Diagnostic imaging is also used to monitor how the patient's body responds to the treatment being given. Diagnostic imaging diagnoses disease early and significantly improves patient survival outcomes. It is a painless technique and offers a rapid diagnosis. The diagnostic imaging industry has been revolutionized from bedside monitoring to high-end digital scanning.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases

The rising prevalence of various chronic diseases propels the market growth. For instance, according to an article published by nih.gov in January 2023, in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases.

Moreover, according to wcrf.org, including non-melanoma skin cancer (NMSC) there were 19,976,499 cancer cases in 2022. When NMSC was excluded, this number dropped to 18,741,966 cancer cases around the world in 2022. Of these, 9,566,825 were in men and 9,175,141 in women. Moreover, according to IARC, There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally).

Restraints

Factors such as high cost associated with the treatment, lack of healthcare infrastructure, and shortage of skilled professionals are expected to hamper the market are expected to hamper the market.

Market Segment Analysis

The global diagnostic imaging equipment market is segmented based on product type, application, end-user, and region.

The X-ray accounted for approximately 48.6% of the global diagnostic imaging equipment market share

The X-ray segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements drive this market.

X-rays are a form of electromagnetic radiation, similar to visible light. Unlike light, however, x-rays have higher energy and can pass through most objects, including the body. Medical X-rays are used to generate images of tissues and structures inside the body. If X-rays traveling through the body also pass through an X-ray detector on the other side of the patient, an image will be formed that represents the "shadows" formed by the objects inside of the body.

For instance, in January 2024, Carestream Health launched a new x-ray system called DXR-Excel Plus with features designed to help simplify workflow and enhance productivity. DXR-Excel Plus is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of exams while providing features that help create an enhanced experience for users, patients, and administrators.

Market Geographical Share

North America accounted for approximately 42.8% of the global diagnostic imaging equipment market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic diseases, and technological advancements, in this region, help to propel the market.

For instance, according to an article published by nih.gov in January 2024, 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

Moreover, in June 2024, Smiths Detection launched its latest X-ray scanner powered by diffraction technology SDX 10060 XDi. X-ray Diffraction (XRD) is a powerful inspection technology offering highly accurate material discrimination and substance identification based on an object's molecular structure. XRD is particularly suited to detecting constantly evolving compounds in powder, liquid, or solid forms, such as 'homemade' explosives or narcotics, even for materials with similar densities.

Market Segmentation

By Product Type

X-ray

Computed Tomography

Ultrasound

Magnetic Resonance Imaging

Nuclear Imaging

Tactile Imaging

Photoacoustic Imaging

Thermography

Elastography

Echocardiography

Functional Near-Infrared Spectroscopy

Mammography

By Application

Cardiology

Orthopedics

Gastroenterology

Gynecology

Oncology

Neurology

Others

By End-User

Hospitals And Clinics

Diagnostic Imaging Centers

Other

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global diagnostic imaging equipment market include GE Healthcare, Shimadzu Corporation, Philips Healthcare, Genesis Medical Imaging Inc., Hologic Inc., Siemens Healthcare, Samsung Medison Co. Ltd, Carestream Health Inc., Hitachi Medical Corporation and Toshiba Corporation among others.

Key Developments

In February 2024, Philips Healthcare announced the launch of a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology right now is endovascular aortic procedures.

In March 2024, Philips Healthcare introduced a new computed tomography system this week at the European Congress of Radiology (ECR) aimed at the rapidly growing cardiac coronary CT angiography (CCTA) market. It features a new detector that was designed to optimize the use of artificial intelligence (AI) image reconstruction algorithms. The new CT 5300 system provides more accurate and reliable imaging results to better manage the increase in complex cardiac cases.

In February 2024, A&M Life Solutions, a certified public procurement supplier of medical devices/healthcare services in collaboration with Fujifilm, launched a mobile X-ray device into the market known as the Fujifilm Xair, the device is a mobile X-ray solution with AI, mainly for Occupational Healthcare. It can generate reports on site for most communicable diseases such as Tuberculosis (TB), COVID-19, etc for chest-related issues, extremities, and emergencies or accident X-ray diagnoses.

Why Purchase the Report?

To visualize the global diagnostic imaging equipment market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global diagnostic imaging equipment market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global diagnostic imaging equipment market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. High Cost Associated with Procedures
  - 4.1.2.2. Lack of Healthcare Infrastructure
  - 4.1.2.3. Shortage of Skilled Professionals
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. X-Ray*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Computed Tomography
6.4. Ultrasound
6.5. Magnetic Resonance Imaging
6.6. Nuclear Imaging
6.7. Tactile Imaging
6.8. Photoacoustic Imaging
6.9. Thermography
6.10. Elastography
6.11. Echocardiography
6.12. Functional Near Infrared Spectroscopy
6.13. Mammography

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Cardiology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Orthopedics
7.4. Gastroenterology
7.5. Gynecology
7.6. Oncology
7.7. Neurology
7.8. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals and Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Imaging Centers
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Shimadzu Corporation
11.3. Koninklijke Philips N.V
11.4. Genesis Medical Imaging Inc.
11.5. Hologic Inc.
11.6. Siemens Healthcare
11.7. Samsung Medison Co. Ltd.
11.8. Carestream Health Inc.
11.9. Hitachi Medical Corporation
11.10. Toshiba Corporation (*LIST NOT EXHAUSTIVE)